TrialPloS one2018

Coagulation biomarkers and prediction of venous thromboembolism and survival in small cell lung cancer: A sub-study of RASTEN - A randomized trial with low molecular weight heparin.

E Gezelius et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.